Clinical trialNCT02796651CompletedPhase 2Interventional

Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)

SponsorAstraZenecaEnrollment132Chronic Obstructive Pulmonary Disease - COPD

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To assess the bronchodilation of three doses of formoterol fumarate (6 μg, 12 μg and 24 μg) twice daily (BID) administered via Pressair® compared to placebo and to open-label nebulized formoterol fumarate (20 μg and 40 μg).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Mark H. Gotfried, MD
1112 East McDowell Road, Phoenix, AZ 85006, United States.
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Glendale, Arizona, United States
Research Site
Phoenix, Arizona, United States
Research Site
Tempe, Arizona, United States
Research Site
Celebration, Florida, United States
Research Site
Clearwater, Florida, United States
Research Site
DeLand, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
Lawrenceville, Georgia, United States
Research Site
St Louis, Missouri, United States
Research Site
Las Vegas, Nevada, United States
Research Site
Charlotte, North Carolina, United States
Research Site
Gastonia, North Carolina, United States
Research Site
Medford, Oregon, United States
Research Site
Portland, Oregon, United States
Research Site
Easley, South Carolina, United States
Research Site
Greenville, South Carolina, United States
Research Site
Rock Hill, South Carolina, United States
Research Site
Spartanburg, South Carolina, United States
Research Site
Boerne, Texas, United States
Research Site
Killeen, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Formoterol →Formoterol furmaratePlacebo for formoterol fumarate

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2016
Primary completion: 7 Dec 2016
Completion: 7 Dec 2016
Last update posted: 7 Feb 2018
Registered enrollment: 132
Registry id: NCT02796651

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.